Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
Long-Term Debt
Beijing Hotgen Biotech Co Ltd
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Long-Term Debt
¥7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Long-Term Debt
¥1.8B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Long-Term Debt
¥8.8B
|
CAGR 3-Years
114%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Long-Term Debt
¥3.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Long-Term Debt
¥857.3m
|
CAGR 3-Years
45%
|
CAGR 5-Years
236%
|
CAGR 10-Years
N/A
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Long-Term Debt
¥77.7m
|
CAGR 3-Years
165%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Long-Term Debt?
Long-Term Debt
7.8m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Long-Term Debt amounts to 7.8m CNY.
What is Beijing Hotgen Biotech Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 1Y
-45%
Over the last year, the Long-Term Debt growth was -45%.